These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 30021518)

  • 21. Efficacy and Safety of the Duodeno-Jejunal Bypass Liner in Patients With Metabolic Syndrome: A Multicenter Randomized Controlled Trial (ENDOMETAB).
    Caiazzo R; Branche J; Raverdy V; Czernichow S; Carette C; Robert M; Disse E; Barthet M; Cariou B; Msika S; Behal H; Denies F; Dervaux B; Duhamel A; Verkindt H; Pattou F
    Ann Surg; 2020 Nov; 272(5):696-702. PubMed ID: 32889869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trends in BMI, Glycemic Control and Obesity-Associated Comorbidities After Explantation of the Duodenal-Jejunal Bypass Liner (DJBL).
    Riedel N; Laubner K; Lautenbach A; Schön G; Schlensak M; Stengel R; Eberl T; Dederichs F; Aberle J; Seufert J
    Obes Surg; 2018 Aug; 28(8):2187-2196. PubMed ID: 29504053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline glycated hemoglobin levels are associated with duodenal-jejunal bypass liner-induced weight loss in obese patients.
    Muñoz R; Dominguez A; Muñoz F; Muñoz C; Slako M; Turiel D; Pimentel F; Sharp A; Escalona A
    Surg Endosc; 2014 Apr; 28(4):1056-62. PubMed ID: 24196558
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intragastric balloon outcomes in super-obesity: a 16-year city center hospital series.
    Ashrafian H; Monnich M; Braby TS; Smellie J; Bonanomi G; Efthimiou E
    Surg Obes Relat Dis; 2018 Nov; 14(11):1691-1699. PubMed ID: 30193905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endoscopic treatment of obesity and complications after bariatric surgery.
    Schlosser T; Feisthammel J; Moessner J; Hoffmeister A
    Minerva Chir; 2017 Dec; 72(6):530-537. PubMed ID: 29072419
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial.
    Courcoulas A; Abu Dayyeh BK; Eaton L; Robinson J; Woodman G; Fusco M; Shayani V; Billy H; Pambianco D; Gostout C
    Int J Obes (Lond); 2017 Mar; 41(3):427-433. PubMed ID: 28017964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study.
    Betzel B; Homan J; Aarts EO; Janssen IMC; de Boer H; Wahab PJ; Groenen MJM; Berends FJ
    Surg Endosc; 2017 Jul; 31(7):2881-2891. PubMed ID: 27804045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of a duodenal-jejunal bypass liner on lipid profile and blood concentrations of long chain polyunsaturated fatty acids.
    Glaysher MA; Ward J; Aldhwayan M; Ruban A; Prechtl CG; Fisk HL; Chhina N; Al-Najim W; Smith C; Klimowska-Nassar N; Johnson N; Falaschetti E; Goldstone AP; Miras AD; Byrne JP; Calder PC; Teare JP
    Clin Nutr; 2021 Apr; 40(4):2343-2354. PubMed ID: 33131909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effectiveness and Safety of the Duodenal-Jejunal Bypass Liner (DJBL) for the Management of Obesity and Glycaemic Control: a Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Yvamoto EY; de Moura DTH; Proença IM; do Monte Junior ES; Ribeiro IB; Ribas PHBV; Hemerly MC; de Oliveira VL; Sánchez-Luna SA; Bernardo WM; de Moura EGH
    Obes Surg; 2023 Feb; 33(2):585-599. PubMed ID: 36508156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity.
    Ponce J; Woodman G; Swain J; Wilson E; English W; Ikramuddin S; Bour E; Edmundowicz S; Snyder B; Soto F; Sullivan S; Holcomb R; Lehmann J;
    Surg Obes Relat Dis; 2015; 11(4):874-81. PubMed ID: 25868829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomes.
    Colás A; Varela M; Mraz M; Novak D; Cuesta-Frau D; Vigil L; Benes M; Pelikanova T; Haluzik M; Burda V; Vargas B
    Diabetes Metab Res Rev; 2020 May; 36(4):e3287. PubMed ID: 31916665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery.
    Tarnoff M; Rodriguez L; Escalona A; Ramos A; Neto M; Alamo M; Reyes E; Pimentel F; Ibanez L
    Surg Endosc; 2009 Mar; 23(3):650-6. PubMed ID: 19067075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duodenal-Jejunal Bypass Liner for the management of Type 2 Diabetes Mellitus and Obesity: A Multicenter Randomized Controlled Trial.
    Ruban A; Miras AD; Glaysher MA; Goldstone AP; Prechtl CG; Johnson N; Chhina N; Al-Najim W; Aldhwayan M; Klimowska-Nassar N; Smith C; Lord J; Li JV; Flores L; Al-Lababidi M; Dimitriadis GK; Patel M; Moore M; Chahal H; Ahmed AR; Cousins J; Aldubaikhi G; Glover B; Falaschetti E; Ashrafian H; Roux CWL; Darzi A; Byrne JP; Teare JP
    Ann Surg; 2022 Mar; 275(3):440-447. PubMed ID: 34647708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained weight loss after duodenal-jejunal bypass liner treatment in patients with body mass index below, but not above 35 kg/m
    Boonchaya-Anant P; Bueter M; Gubler C; Gerber PA
    Clin Obes; 2023 Feb; 13(1):e12561. PubMed ID: 36239531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term Results of Duodeno-jejunal Bypass in the Treatment of Obesity and Type 2 Diabetes.
    Kral J; Benes M; Lanska V; Macinga P; Drastich P; Spicak J; Hucl T
    Obes Surg; 2024 May; 34(5):1407-1414. PubMed ID: 38436919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intragastric Balloon Treatment for Obesity: Review of Recent Studies.
    Tate CM; Geliebter A
    Adv Ther; 2017 Aug; 34(8):1859-1875. PubMed ID: 28707286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duodenal-jejunal bypass liners: outcomes in glycaemic control and weight loss.
    Neff KJ; Miras AD; le Roux C
    Curr Opin Endocrinol Diabetes Obes; 2013 Oct; 20(5):420-8. PubMed ID: 23974770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Patients With Type 2 Diabetes With Obesity: A Meta-analysis With Secondary Analysis on Weight Loss and Hormonal Changes.
    Jirapinyo P; Haas AV; Thompson CC
    Diabetes Care; 2018 May; 41(5):1106-1115. PubMed ID: 29678867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up.
    Mathus-Vliegen EM; Tytgat GN
    Gastrointest Endosc; 2005 Jan; 61(1):19-27. PubMed ID: 15672051
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.